Enhancing Access to Medications for Opioid Use Disorder for Patients in Hospital Settings
Alane O’Connor, DNP, and Rachel Solotaroff, MD, will review the recent guidance document on enhancing access to Medications for Opioid Use Disorder (MOUD) for patients in hospital settings developed by the Maine Opioid Response Clinical Advisory Committee. This will include discussion of the recommendations for a basic level of care for patients with OUD in both Emergency Department (ED) and inpatient hospital settings, as well as recommendations for hospitals with the ability to provide a more advanced level of care. Policy recommendations to support MOUD in the hospital setting will also be addressed.
Objectives:
Describe expectations for hospitals to provide a basic level of care for patients with OUD in the ED and inpatient hospital setting
Describe expectations for hospitals able to provide an advanced level of care for patients with OUD
Identify resources to assist implementation of care for patients with OUD in ED and inpatient and hospital settings
Audience:
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact Hours
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals
1 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
1 contact hour pending for alcohol and drug counselors from the board of alcohol and drug counselors
Speakers
-
Alane O'Connor DNPDr. Alane O’Connor DNP is the Director of Perinatal Addiction Medicine at MaineHealth Maine Medical Center and served as the medical director of the Maine Maternal Opioid Misuse (MaineMOM) Initiative, a 5-year, $5 million federal grant to expand access to substance use treatment for pregnant and postpartum women. She has trained hundreds of resident physicians and fellows and is core faculty in Maine’s only addiction medicine fellowship. Dr. O’Connor has published more than a dozen peer-reviewed manuscripts on maternal and infant outcomes following treatment with medication for opioid use disorder during pregnancy as well as related postpartum healthcare utilization and health policy. , She developed a partnership with Portland Fire Department’s Mobile Medical Outreach (MMO) team after recognizing that some of her most at-risk pregnant women were not accessing health care in traditional settings. Project Lifeline is a nationally innovative medical and community paramedicine program that delivers street medicine services to unhoused pregnant and postpartum women with substance use disorder who live in tents, shelters, vehicles, and on the street.
Beyond caring for pregnant women, Dr. O’Connor works in the correctional system as the Director of Addiction Medicine at Somerset County Jail and Franklin County Detention Center and is the clinical advisor to the Maine Sheriffs’ Association. In this capacity, she developed and implemented a nationally innovative program using a monthly injectable medication (rather than a daily pill) to treat incarcerate individuals with opioid use disorder. The outcomes, published in Health & Justice, showed that the injectable medication expanded access to treatment during incarceration, improved treatment continuation after release and reduced the risk of post-release drug overdose death. The project gained nationwide attention and was featured on the front page of the New York Times and a related podcast.
Dr. O’Connor lectures regionally and nationally on substance use disorder to a variety of audiences including medical providers, the child welfare system, the correctional system and judiciary, as well as law enforcement. She is a member of the Maine Maternal Fetal and Infant Mortality Review Panel and co-chairs Maine’s Opioid Response Clinical Advisory Committee which advises the state’s opioid response director on clinical and public policy issues.Director of Addiction Medicine Somerset County Jail
– Director of Addiction Medicine Franclin County Detention Center
– Director, MaineHealth Maine Medical Center Perinatal Addiction Medicine
– Director, MaineHealth Maine Medical Center Correctional Addiction Medicine
– Assistant Clinical Professor, Tufts University School of Medicine
– MaineHealth Comprehensive Addiction Medicine -
Rachel Solotaroff MD MCRRachel Solotaroff, MD, MCR is the Clinical Advisor for Substance Use Disorders at
Penobscot Community Health Care, where she oversees substance use disorders care delivery in the outpatient and inpatient settings. She is also the Medical Director at New Horizons Detox in Hampden,; and the Medical Director at Milestone Recovery, in Portland, Maine. Prior to moving to Maine, Rachel served for nearly 20 years as Chief Medical Officer and then CEO at Central City Concern, an organization that provides health care, supportive housing and supported employment to people experiencing homelessness in Portland, Oregon. Her work has focused on applying a population health approach to the intersection of homelessness, substance use disorders, mental health, trauma, and social isolation. Rachel is a general internist with additional board certification in Addiction Medicine, and holds a Masters in Clinical Research.
